The new BNP control from Randox, UK, with US headquarters in Kearneysville, WVa, comes as a 100% human serum, manufactured to the quality standards associated with all Acusera controls.
This comes as a liquid, ready-to-use format in 1-ml vials, making it well suited for point-of-care testing.
The 30-day open vial stability, along with the vial size, helps reduce any waste.
Assayed instrument-specific target values and ranges are provided for a range of instruments, including Beckman Access, Abbott Architect, and Siemens Advia Centaur.
[Source: Randox]